Tumor suppressor activities have been shown for DAPk1 and DAPk2 and they are downregulated in e.g., Hodgkin’s (HL) and B cell lymphoma (CLL), respectively. The gene discussed is DAPK2; the disease is B-cell non-Hodgkin lymphoma.